The Ministry of Health has launched the use of Lenacapavir, a revolutionary Pre-Exposure Prophylaxis long-acting injectable ...

Monthly injectable HIV therapy shows lower treatment failure than oral regimens in individuals with adherence challenges.

Daily oral PrEP (generic Truvada; Descovy) is effective but adherence-sensitive, and seroconversions in trials correlate with ...

Len is a gamechanging drug to prevent HIV infections, priced by Gilead at $28,200. Limited drug is available at cost to ...

When it comes to HIV medication, many patients think they'd prefer an occasional injection over a daily pill, but uptake ...

Adolescents with Human Immunodeficiency Virus (HIV) in Botswana, South Africa, Thailand, Uganda and the United States who received the injectable intramuscular antiviral medications cabotegravir and ...

St. Jude Children’s Research Hospital in Memphis, Tenn., is leading two clinical trials aimed at expanding HIV treatment and prevention options for the youngest pediatric populations. The hospital was ...

Lenacapavir is a long-acting injectable Pre-Exposure Prophylaxis (PrEP) option administered once every six months ...

Dr Jane Ruth Aceng says Uganda is committed to ending AIDS as a public health threat by 2030 through a combination prevention ...

It is a win in the fight against new HIV infections, as Kenya is set to receive the first batch of injectable HIV prevention drugs. Kenya will receive a total of 110,000 doses of injectable HIV ...

The twice-yearly HIV injectable drug launch was presided over by the Health Minister and Lira City Woman MP, Dr Jane Ruth Aceng, at Lira Regional Referral Hospital.

First and corresponding author on one study and co-senior author on the other, Aditya Gaur, MD, St. Jude Department of Infectious Diseases, who co-leads the IMPAACT 2017 study, also referred to as the ...